In this CME-certified video module, Keith C. Ferdinand, MD, FACC, FAHA, discusses approaches to recognizing patients with elevated HF risk, using biomarkers to support HF diagnosis and prognosis, and integrating the latest treatment options into evidence-based management therapies, with a focus on treating special patient populations.
In this downloadable slideset, Keith C. Ferdinand, MD, FACC, FAHA, reviews risk factors for HF, the use of biomarkers to support HF diagnosis and prognosis, and the latest HF treatment strategies, with a focus on treating special patient populations.
I describe how biomarkers such as BNP and NT-proBNP can help influence decisions about the diagnosis and prognosis of heart failure.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.